...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Veterinary Applications?

Thanks Bear -

That is encouraging.

Now...how to find out more...

For some reason, i don't seem to get the Zenith notices (the few they do send out), maybe because i am such a tiny shareholder

Appreciated! 

Share
New Message
Please login to post a reply